Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 11, 2009, Pages 1039-1047

  Jacobsson, Ingela ^a   Jönsson, Anna K ^a,b   Gerdén, Barbro ^c   Hägg, Staffan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Adverse drug reaction; Adverse drug reaction reporting systems; Complementary and alternative medicine; Drug interaction; Herbal drugs

Indexed keywords

COD LIVER OIL; ECHINACEA PURPUREA EXTRACT; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; WARFARIN;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ALTERNATIVE MEDICINE; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CONTACT DERMATITIS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ECHINACEA PURPUREA; ELEUTHEROCOCCUS SENTICOSUS; FEMALE; GINKGO BILOBA; HUMAN; HYPERICUM PERFORATUM; INFANT; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASE; LIVER NECROSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NUT; PLANT LEAF; PRIORITY JOURNAL; RASH; SWEDEN; URTICARIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMPLEMENTARY THERAPIES; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PLANT PREPARATIONS; SWEDEN; YOUNG ADULT;

EID: 70549103448     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1818     Document Type: Article

References (19)

1. Kelly JP, Kaufman MS, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal medicine and other natural products. Arch Intern Med 2005; 165: 281-286. (Pubitemid 40216279)
2. Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within the northern Sweden MONICA Project. Multinational monitoring of trends and determinants of cardiovascular disease. J Intern Med 2001; 250: 225-233.
3. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997 : results of a followup national survey. JAMA 1998; 280: 1569-1575.
4. Ernst E, White A. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000; 8: 32-36. (Pubitemid 30189587)
5. Hanssen B, Grimsgaard S, Launso L, Fonnebo V, Falkenberg T, Rasmussen NK. Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care 2005; 23: 57-62. (Pubitemid 41647166)
6. Giveon S, Liberman N, Klang S, Kahan E. Are people who use "natural drugs" aware of their potentially harmful side effects and reporting to the family physician? Patient Educ Couns 2004; 53: 5-11.
7. De Smet PA. Herbal remedies. N Engl J Med 2002; 347(25): 2046-2056.
8. Niggemann B, Gruber C. Side effect of complementary and alternative medicine. Allergy 2003; 58: 707-716. (Pubitemid 36920457)
9. Skalli S, Zaid A, Soulaymani R. Drug interactions with herbal medicines. Ther Drug Monit 2007; 29: 679-686.
10. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61: 2163-2175. (Pubitemid 34074799)
11. De Smet PA. Health risks of herbal remedies. Drug Saf 1995; 13: 81-93.
12. World Health Organisation Collaborating Centre for International Drug Monitoring. Adverse reaction terminology. 31 December 1991.
13. World Health Organisation. Causality Assessment of Suspected Adverse Reactions. Available at; www.who-umc.org/DynPage. aspx?id=22682. Last accessed: [12 December 2008].
14. Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000; 9: 105-112. (Pubitemid 30307351)
15. Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-276.
16. Menneti-Ippolito F, Mazzanti G, Santuccio C, et al. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol Drug Saf 2008; 17: 626-635. (Pubitemid 351982769)
17. Huntley AL, Thompson Coon J, Ernst E. The safety of herbal medicinal products derived from Echinacea species. A systematic review. Drug Saf 2005; 28: 387-400.
18. Parnham MJ. Benefit-risk assessment of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulation. Phytomedicine 1996; 3: 95-102.
19. Mullins RJ, Heddle R. Adverse reactions associated with Echinacea: the Australian experience. Ann Allergy Asthma Immunol 2002; 88: 42-51. (Pubitemid 34059649)